Jubilant Ingrevia Limited (JUBLINGREA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jubilant Ingrevia Limited (JUBLINGREA) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs970.80 Million ≈ $10.50 Million USD) by net assets (Rs30.41 Billion ≈ $328.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see JUBLINGREA company net worth for the company's overall valuation and market capitalisation.
Jubilant Ingrevia Limited - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Jubilant Ingrevia Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jubilant Ingrevia Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jubilant Ingrevia Limited ranked by their cash flow conversion efficiency. Explore JUBLINGREA cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
|
0.025x |
|
MAGYAR TELE.A ADR/5 UF100
F:MGYA
|
N/A |
|
Shandong Head Co Ltd
SHE:002810
|
0.027x |
|
Hangzhou Cogeneration Group Co Ltd
SHG:605011
|
0.006x |
|
Zhejiang Huangma Technology Co Ltd
SHG:603181
|
0.043x |
|
KBC Corporation Ltd
SHG:688598
|
-0.008x |
|
Yapp Automotive Systems Co Ltd
SHG:603013
|
0.242x |
|
Total Gabon
F:RZW
|
0.045x |
Annual Cash Flow Conversion Efficiency for Jubilant Ingrevia Limited (2020–2025)
The table below shows the annual cash flow conversion efficiency of Jubilant Ingrevia Limited from 2020 to 2025. View JUBLINGREA live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs29.27 Billion ≈ $316.55 Million |
Rs5.08 Billion ≈ $54.95 Million |
0.174x | +10.51% |
| 2024-03-31 | Rs27.37 Billion ≈ $296.05 Million |
Rs4.30 Billion ≈ $46.50 Million |
0.157x | -9.44% |
| 2023-03-31 | Rs26.66 Billion ≈ $288.34 Million |
Rs4.62 Billion ≈ $50.01 Million |
0.173x | -6.79% |
| 2022-03-31 | Rs24.33 Billion ≈ $263.13 Million |
Rs4.53 Billion ≈ $48.96 Million |
0.186x | +247.89% |
| 2021-03-31 | Rs19.23 Billion ≈ $207.96 Million |
Rs1.03 Billion ≈ $11.12 Million |
0.053x | +101.55% |
| 2020-03-31 | Rs-1.16 Million ≈ $-12.51K |
Rs3.98 Million ≈ $43.09K |
-3.443x | -- |
About Jubilant Ingrevia Limited
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing servic… Read more